Snell & Wilmer has advised Traws Pharma, Inc. Traws Pharma, Inc. (Nasdaq: TRAW), a clinical-stage biopharmaceutical company, has entered into a securities purchase agreement with new…
Traws Pharma Secures Up to $60 Million in Private Placement Financing
